These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2876571)
1. Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995). Williams G; Kraenzlin M; Sandler L; Burrin J; Law A; Bloom S; Joplin GF Acta Endocrinol (Copenh); 1986 Sep; 113(1):42-6. PubMed ID: 2876571 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion. Williams G; Anderson JV; Williams SJ; Bloom SR Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335 [TBL] [Abstract][Full Text] [Related]
3. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. Beck-Peccoz P; Mariotti S; Guillausseau PJ; Medri G; Piscitelli G; Bertoli A; Barbarino A; Rondena M; Chanson P; Pinchera A J Clin Endocrinol Metab; 1989 Jan; 68(1):208-14. PubMed ID: 2491862 [TBL] [Abstract][Full Text] [Related]
4. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Mannavola D; Persani L; Vannucchi G; Zanardelli M; Fugazzola L; Verga U; Facchetti M; Beck-Peccoz P Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193 [TBL] [Abstract][Full Text] [Related]
5. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. Comi RJ; Gesundheit N; Murray L; Gorden P; Weintraub BD N Engl J Med; 1987 Jul; 317(1):12-7. PubMed ID: 2884564 [TBL] [Abstract][Full Text] [Related]
6. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma. Wémeau JL; Dewailly D; Leroy R; D'Herbomez M; Mazzuca M; Decoulx M; Jaquet P J Clin Endocrinol Metab; 1988 Mar; 66(3):636-9. PubMed ID: 2895119 [TBL] [Abstract][Full Text] [Related]
7. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature. Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085 [TBL] [Abstract][Full Text] [Related]
8. Inappropriate TSH secretion with abnormal thyrotroph sensitivity to dopamine. Drucker D; Josse R Clin Invest Med; 1985; 8(2):117-20. PubMed ID: 3938686 [TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses. Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339 [TBL] [Abstract][Full Text] [Related]
10. [Hyperthyroidism caused by non-neoplastic inappropriate TSH secretion]. Agapito A; Guerra L; Afonso A; Fonseca F; Malheiro F; da Costa C Acta Med Port; 1992 Feb; 5(2):104-6. PubMed ID: 1595367 [TBL] [Abstract][Full Text] [Related]
11. Inappropriate secretion of thyrotropin by the pituitary. Faglia G; Beck-Peccoz P; Piscitelli G; Medri G Horm Res; 1987; 26(1-4):79-99. PubMed ID: 3297965 [TBL] [Abstract][Full Text] [Related]
12. A case of inappropriate non-neoplastic secretion of TSH treated with bromocriptine. Yeğen C; Aktan AO; Saraç AM; Yalin R Endocr Regul; 1993 Mar; 27(1):23-5. PubMed ID: 8003703 [TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management. Hermus A; Ross H; van Liessum P; Naber A; Smals A; Kloppenborg P Neth J Med; 1991 Jun; 38(5-6):193-8. PubMed ID: 1922591 [TBL] [Abstract][Full Text] [Related]
14. The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism. Gharib H; Carpenter PC; Scheithauer BW; Service FJ Mayo Clin Proc; 1982 Sep; 57(9):556-63. PubMed ID: 7109684 [TBL] [Abstract][Full Text] [Related]
15. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy. Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960 [TBL] [Abstract][Full Text] [Related]
17. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases. Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054 [TBL] [Abstract][Full Text] [Related]
18. Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995. Beck-Peccoz P; Medri G; Piscitelli G; Mariotti S; Bertoli A; Barbarino A; Rondena M; Martino E; Pinchera A; Faglia G Horm Res; 1988; 29(2-3):121-3. PubMed ID: 2900192 [TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism due to a thyrotropin-secreting pituitary adenoma. Studies of thyrotropin and subunit secretion. Smith CE; Smallridge RC; Dimond RC; Wartofsky L Arch Intern Med; 1982 Sep; 142(9):1709-11. PubMed ID: 6810781 [TBL] [Abstract][Full Text] [Related]
20. A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment. Polak M; Bertherat J; Li JY; Kujas M; Le Dafniet M; Weizani H; Van Effenterre R; Epelbaum J; Turpin G Acta Endocrinol (Copenh); 1991 Apr; 124(4):479-86. PubMed ID: 1851593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]